For Forest, Two Launches And Two Filings Planned In 2011 As Patent Cliff Looms
This article was originally published in The Pink Sheet Daily
Executive Summary
On the heels of a strong quarter, Forest has launched the antibiotic Teflaro and plans to introduce the oral COPD candidate Daxas, later this year pending FDA approval.